Archive for ◊ December, 2013 ◊

• Thursday, December 12th, 2013

Henry Schein Announces $300 Million Increase To Share Repurchase Plan MELVILLE, N.Y., Dec. 10, 2013 /PRNewswire/ — Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of health care products and services to office-based dental, animal and medical practitioners, today announced that its Board of Directors has authorized the repurchase of up to $300 million of shares of the Company’s […]

• Thursday, December 12th, 2013

Hologic, Inc. (HOLX) Expands Its Board Of Directors With Appointment Of Two Independent Directors And BEDFORD, Mass., Dec. 9, 2013 /PRNewswire/ — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today […]

• Thursday, December 12th, 2013

For many women, monthly menstrual cramps can stop them in their tracks, causing nausea, vomiting, diarrhea and dizziness. But according to researchers from Penn State College of Medicines, a common drug used to treat erectile dysfunction in men could provide some relief. In a recent study published in the journal Human Reproduction, the researchers, led by […]

• Wednesday, December 11th, 2013

NEW YORK, Dec. 5, 2013 — /PRNewswire/ — JARVIK HEART, Inc., a privately-held company that develops and manufactures cardiac assist devices, announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval to the Shonin (or pre-market approval) application submitted by Century Medical, Inc., (CMI) for the Jarvik 2000 Heart, a small Left […]

• Wednesday, December 11th, 2013

Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER Stent System NATICK, Mass. and PARSIPPANY, N.J., Dec. 6, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) and The Medicines Company (NASDAQ: MDCO) announce a co-promotion agreement for the Boston Scientific Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System. Under the terms of the agreement, The […]

• Wednesday, December 11th, 2013

American doctors have begun implanting a new deep-brain stimulation system by Medtronic Inc. that senses and records brain activity at the same time it delivers therapy to treat Parkinson’s symptoms, essential tremors and epilepsy, the company announced Thursday. The Activa PC+S deep-brain stimulation system may allow researchers to actually make the link to brain signals […]

• Wednesday, December 11th, 2013

Israeli medtech company Lumenis files for an initial public offering worth $115 million. Lumenis Ltd., an Israeli medtech company that makes lasers used in eye surgery, urology and cosmetic medical procedures, filed today for an initial public offering worth $115 million. Yokneam, Israel-based Lumenis said it plans to trade on the NASDAQ stock exchange under […]

• Friday, December 06th, 2013

AngioDynamics Announces Operational Excellence Program ALBANY, N.Y., Dec 05, 2013 (GLOBE NEWSWIRE via COMTEX) — AngioDynamics ANGO +1.50% , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today a Company-wide operational excellence program designed to save $15 million to $18 million during the course […]

• Friday, December 06th, 2013

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Global Fund to Fight AIDS, Tuberculosis and Malaria has announced a broad-based partnership to help prevent patients from being harmed by fake medicines. Fake medicines put patients and the general public at risk. Patients believe they are receiving genuine treatment, when instead they are getting […]

• Friday, December 06th, 2013

Medtronic’s cardiac and vascular group president, Michael Coyle, questions CardioMEMS’ implantable heart monitor, citing Medtronic’s experience with its now-abandoned Chronicle monitor. The Champion implantable heart monitor made by CardioMEMS might not prove as cost-effective as a non-invasive approach, at least according to Medtronic (NYSE:MDT) cardiac and vascular group president Michael Coyle. Coyle, speaking at the 25th Annual […]